3N96
Crystal structure of human CRFR2 alpha extracellular domain in complex with Urocortin 1
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 21-ID-F |
Synchrotron site | APS |
Beamline | 21-ID-F |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 1.07818 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 54.063, 211.551, 107.839 |
Unit cell angles | 90.00, 104.37, 90.00 |
Refinement procedure
Resolution | 50.000 - 2.750 |
R-factor | 0.237 |
Rwork | 0.235 |
R-free | 0.27300 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3n93 |
RMSD bond length | 0.017 |
RMSD bond angle | 1.618 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASES |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.850 |
High resolution limit [Å] | 2.750 | 2.750 |
Rmerge | 0.141 | 0.690 |
Number of reflections | 59140 | |
<I/σ(I)> | 12.6 | 2.1 |
Completeness [%] | 95.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 4.6 | 293 | 10% PEG 6000 0.1M Sodium acetate(pH 4.6) 0.1M MgCl2 14% Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K |